Drugs / Lipovenoes
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00929461 Background | — | — | Ege University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipovenoes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00929461 ↗ |
| Known as | Lipovenoes 10% | “0.8 g/kg BW omega-6 fatty acids (Lipovenoes® 10%, Fresenius-Kabi) were provided to both groups through an indwelling central venous catheter.” NCT00929461 ↗ |
| Route | Intravenous | “through an indwelling central venous catheter” NCT00929461 ↗ |